Park Place Capital’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Park Place Capital’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-500	Closed	-$43.5K	–	864
2024 Q3	$43.5K	Hold	500	–	–	0.01%	387
2024 Q2	$41.1K	Hold	500	–	–	0.01%	386
2024 Q1	$40.1K	Hold	500	–	–	0.01%	429
2023 Q4	$38K	Hold	500	–	–	0.02%	450
2023 Q3	$36.2K	Hold	500	–	–	0.01%	531
2023 Q2	$37.8K	Hold	500	–	–	0.01%	538
2023 Q1	$38K	Hold	500	–	–	0.01%	532
2022 Q4	$39K	Buy	+500	New	+$38.4K	0.01%	524

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

MWM

MGB Wealth Management Addison, Texas $350M AUM 42.75% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Park Place Capital's PJP Position: Q4 2024 in Review

Park Place Capital sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2024, closing a stake of 500 shares — an estimated $43.5K sold.

Park Place Capital first reported a position in PJP in Q4 2022 and held it in 8 quarters. The position peaked at $43.5K in Q3 2024. 93 funds tracked by Wall St. Rank hold PJP as of Q4 2024.

Park Place Capital reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2024 after selling out during the quarter.
Park Place Capital sold 500 Invesco Pharmaceuticals ETF shares in Q4 2024, an estimated $43.5K.
Park Place Capital first reported a position in Invesco Pharmaceuticals ETF in Q4 2022 and held it in 8 quarters.
Park Place Capital's Invesco Pharmaceuticals ETF position peaked at $43.5K in Q3 2024.
93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2024.

Based on Park Place Capital's 13F filing for Q4 2024, filed 17 Jan 2025.